concept

DLB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DLB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

156Connections

0Hypotheses

0Analyses

50Outgoing

50Incoming

6Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DLB
Key Genes/Proteins	AD, APOE, APP, ATG5, AΒ
Related Diseases	ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS

Wiki Pages (17)

Knowledge base pages for this entity

Canonical Page

DLB Cognitive Fluctuation Mechanism Experiment

experiment · 2588 words

→

DLB, Parkinson's Disease, and Alzheimer's Disease: Cross-Disease Comparison Matrix

disease · 3237 words

→

Pathway Diagram

graph TD
    DLB[DLB]
    DLB ---|co-discussed| PARKINSON[PARKINSON]
    DLB ---|co-discussed| PARKINSON_S[PARKINSON'S]
    DLB ---|co-discussed| PREFRONTAL[PREFRONTAL]
    DLB ---|co-discussed| MICROGLIA[MICROGLIA]
    DLB ---|co-discussed| LOCUS_COERULEUS[LOCUS COERULEUS]
    DLB ---|co-discussed| TAU[TAU]
    MICROGLIA ---|associated| DLB
    ALZHEIMER[ALZHEIMER] ---|co-discussed| DLB
    ALZHEIMER_S[ALZHEIMER'S] ---|co-discussed| DLB
    DEMENTIA[DEMENTIA] ---|co-discussed| DLB
    CORTEX[CORTEX] ---|co-discussed| DLB
    ALS[ALS] ---|co-discussed| DLB

Outgoing (106)

Target	Relation	Type	Str
PROGRESSIVE SUPRANUCLEAR PALSY	interacts_with	disease	0.60
TAU	interacts_with	gene	0.60
TAU	regulates	gene	0.60
MICROGLIA	activates	cell_type	0.60
PARKINSON'S DISEASE	activates	disease	0.60
PD	activates	gene	0.60
NEUROINFLAMMATION	interacts_with	pathway	0.60
PD	co_discussed	gene	0.60
PARKINSON'S DISEASE	co_discussed	disease	0.60
MICROGLIA	associated_with	cell_type	0.60
INFLAMMASOME	activates	pathway	0.60
NLRP3	activates	gene	0.60
OXIDATIVE STRESS	activates	pathway	0.60
PROGRESSIVE SUPRANUCLEAR PALSY	regulates	disease	0.60
PROGRESSIVE SUPRANUCLEAR PALSY	co_discussed	disease	0.60
GBA	expresses	gene	0.60
GBA	associated_with	gene	0.60
SNCA	associated_with	gene	0.60
PARKINSON'S DISEASE	expresses	disease	0.60
PD	regulates	gene	0.60
PARKINSON'S DISEASE	causes	disease	0.60
PD	causes	gene	0.60
NEURON	interacts_with	cell_type	0.60
STING	transports	gene	0.60
GFAP	co_discussed	gene	0.60
TREM2	co_discussed	gene	0.60
NEUROINFLAMMATION	markers	pathway	0.60
TAU	markers	gene	0.60
PSEN1	interacts_with	gene	0.60
PD	protects_against	gene	0.60
STING	associated_with	gene	0.60
OLIGODENDROCYTE	co_discussed	cell_type	0.60
OLIGODENDROCYTES	co_discussed	cell_type	0.60
PARKINSON DISEASE	co_discussed	disease	0.60
FTD	causes	gene	0.60
NEURON	expresses	cell_type	0.60
NEURONS	expresses	cell_type	0.60
NEURON	associated_with	cell_type	0.60
NEURONS	associated_with	cell_type	0.60
FRONTOTEMPORAL DEMENTIA	co_discussed	disease	0.60
TAU	expresses	gene	0.60
NEURON	causes	cell_type	0.60
PINK1	causes	gene	0.60
PINK1	expresses	gene	0.60
PINK1	activates	gene	0.60
LEWY BODY DEMENTIA	co_discussed	disease	0.60
STING	markers	gene	0.60
PARKINSON'S DISEASE	associated_with	disease	0.60
PD	associated_with	gene	0.60
LRP1	associated_with	gene	0.60

Incoming (50)

Source	Relation	Type	Str
MICROGLIA	associated_with	cell_type	0.64
ALZHEIMER'S DISEASE	interacts_with	disease	0.60
AD	co_discussed	gene	0.60
AD	targets	gene	0.60
AD	inhibits	gene	0.60
AD	interacts_with	gene	0.60
AΒ	interacts_with	gene	0.60
CJD	associated_with	gene	0.60
AΒ	co_discussed	gene	0.60
CORTICOBASAL DEGENERATION	co_discussed	disease	0.60
ALZHEIMER'S DISEASE	co_discussed	disease	0.60
AD	regulates	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	co_discussed	disease	0.60
AD	disrupts	gene	0.60
CHOLINERGIC	associated_with	cell_type	0.60
CHOLINERGIC	disrupts	cell_type	0.60
AD	causes	gene	0.60
ALZHEIMER'S DISEASE	causes	disease	0.60
APOE	expresses	gene	0.60
APOE	associated_with	gene	0.60
DJ1	co_discussed	gene	0.60
APOE	causes	gene	0.60
CJD	co_discussed	gene	0.60
CREUTZFELDT-JAKOB	co_discussed	disease	0.60
ALZHEIMER'S DISEASE	regulates	disease	0.60
AD	expresses	gene	0.60
AD	associated_with	gene	0.60
AΒ	associated_with	gene	0.60
AΒ	causes	gene	0.60
APP	expresses	gene	0.60
AΒ	expresses	gene	0.60
ALZHEIMER'S DISEASE	associated_with	disease	0.60
ATG5	regulates	gene	0.60
AD	markers	gene	0.60
ALZHEIMER	co_discussed	entity	0.50
ALZHEIMER'S	co_discussed	entity	0.50
DEMENTIA	co_discussed	entity	0.50
CORTEX	co_discussed	entity	0.50
ATG5	co_discussed	entity	0.50
AUTOPHAGY	co_discussed	entity	0.50
BRAINSTEM	co_discussed	entity	0.50
CHOLINERGIC	co_discussed	entity	0.50
APOE	co_discussed	entity	0.50
CBD	co_discussed	entity	0.50
APP	co_discussed	entity	0.50
CERAMIDE	co_discussed	entity	0.50
ALPHA-SYNUCLEIN	co_discussed	entity	0.50
AXON	co_discussed	entity	0.50
CYTOKINE	co_discussed	entity	0.50
ALS	co_discussed	entity	0.50

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (6)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Tau Co-Pathology in DLB Clinical Heterogeneity	clinical	Neurodegeneration	0.400	0.50	human	proposed	$5,460,000
DLB Treatment Response Biomarkers — Predicting Cholinesterase Inhibito	clinical	Neurodegeneration	0.400	0.50	human	proposed	$6,550,000
Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Map	validation	Parkinson's Disease	0.400	0.50	cell_line	proposed	$160,000
DLB Cognitive Fluctuation Mechanism Experiment	clinical	Neurodegeneration	0.400	0.50	human	proposed	$6,550,000
Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Genetic Risk Modifiers in DLB Phenotype	clinical	Neurodegeneration	0.400	0.50	human	proposed	$7,500,000

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning DLB in their description or question text

No additional research found

DLB

Understanding Entity Pages

Wiki Pages (17)

DLB Cognitive Fluctuation Mechanism Experiment

DLB, Parkinson's Disease, and Alzheimer's Disease: Cross-Disease Comparison Matrix

Dementia with Lewy Bodies (DLB)

DLB, PDD, and Alzheimer's Disease: Cross-Disease Comparison Matrix

Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Restoration

DLB Knowledge Gaps

DLB-PD-AD Cross-Disease Comparison

DLB-PD-AD Comparison Matrix

Alpha-Synuclein Staging and Spreading in DLB — Spatial Propagation Mapping

DLB Cognitive Fluctuation Mechanisms

DLB Autonomic Dysfunction Pathway

DLB Cholinergic Dysfunction Mechanisms

DLB Cure Roadmap

DLB Treatment Response Biomarkers — Predicting Cholinesterase Inhibitor Response

Alpha-Synuclein Prion-Like Propagation in DLB

Genetic Risk Modifiers in DLB Phenotype

Tau Co-Pathology in DLB Clinical Heterogeneity